Clinical Trials Directory

Trials / Completed

CompletedNCT03247400

The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo

The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS)

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Nicolaus Copernicus University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the influence of simvastatin and atorvastatin on vitiligous lesions in patients with non-segmental vitiligo.

Detailed description

According to available data, statins act through several immunological pathways, potentially reversing undesirable phenomena underlying autoimmune vitiligo pathogenesis. A study has been designed as a single-center, randomized, double-blind, placebo-controlled pilot study with the enrollment of at least 20 active non-segmental vitiligo patients presenting with vitiligous lesions on both upper and lower limbs. Clinical effects of ointments containing 1% simvastatin-acid sodium salt or 1% atorvastatin calcium salt applied on a preselected limb will be assessed in comparison with vehicle ointment applied on the opposite limb. All study participants will undergo clinical evaluation using Body Surface Area (BSA) and Vitiligo Area Scoring Index (VASI) scales at baseline, week 4, week 8 and week 12 time points. Precise assessment of skin lesions will be performed using photographic documentation obtained during each study visit and processed with NIS-Elements software.

Conditions

Interventions

TypeNameDescription
DRUG1% simvastatin-acid sodium salt ointment1% simvastatin-acid sodium salt ointment applied onto a predefined limb
DRUG1% atorvastatin calcium salt ointment1% atorvastatin calcium salt ointment applied onto a predefined limb

Timeline

Start date
2016-12-01
Primary completion
2018-12-31
Completion
2019-04-30
First posted
2017-08-11
Last updated
2020-09-23

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03247400. Inclusion in this directory is not an endorsement.